Sio Capital Management as of March 31, 2017
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 46 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Acorda Therapeutics | 12.3 | $22M | 1.0M | 21.00 | |
| Quotient | 9.1 | $16M | 2.3M | 6.99 | |
| Sanofi-Aventis SA (SNY) | 6.8 | $12M | 270k | 45.25 | |
| GlaxoSmithKline | 6.2 | $11M | 262k | 42.16 | |
| Koninklijke Philips Electronics NV (PHG) | 4.4 | $7.8M | 244k | 32.11 | |
| Biogen Idec (BIIB) | 4.2 | $7.6M | 28k | 273.42 | |
| Sage Therapeutics (SAGE) | 4.1 | $7.3M | 103k | 71.07 | |
| Rigel Pharmaceuticals (RIGL) | 3.5 | $6.2M | 1.9M | 3.31 | |
| Puma Biotechnology (PBYI) | 3.3 | $6.0M | 160k | 37.20 | |
| Tabula Rasa Healthcare | 3.1 | $5.6M | 414k | 13.48 | |
| Merck & Co (MRK) | 2.8 | $5.1M | 80k | 63.54 | |
| Eli Lilly & Co. (LLY) | 2.7 | $4.9M | 58k | 84.10 | |
| Aetna | 2.6 | $4.7M | 37k | 127.55 | |
| Cardinal Health (CAH) | 2.6 | $4.7M | 58k | 81.55 | |
| Thermo Fisher Scientific (TMO) | 2.6 | $4.6M | 30k | 153.60 | |
| Advanced Accelerat spon ads each rep 2 ord | 2.4 | $4.3M | 109k | 39.86 | |
| Adamis Pharmaceuticals Corp Com Stk | 2.1 | $3.8M | 883k | 4.25 | |
| Johnson & Johnson (JNJ) | 2.1 | $3.7M | 30k | 124.57 | |
| UnitedHealth (UNH) | 1.9 | $3.5M | 21k | 164.01 | |
| Pfizer (PFE) | 1.9 | $3.4M | 100k | 34.21 | |
| Medtronic (MDT) | 1.4 | $2.4M | 30k | 80.57 | |
| Smith & Nephew (SNN) | 1.3 | $2.4M | 77k | 30.93 | |
| Molina Healthcare (MOH) | 1.3 | $2.3M | 50k | 45.60 | |
| Teva Pharmaceutical Industries (TEVA) | 1.2 | $2.2M | 70k | 32.09 | |
| Boston Scientific Corporation (BSX) | 1.2 | $2.2M | 90k | 24.87 | |
| Chemocentryx | 1.2 | $2.1M | 294k | 7.28 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.2 | $2.1M | 20k | 109.37 | |
| Globus Med Inc cl a (GMED) | 1.0 | $1.8M | 60k | 29.62 | |
| Quintiles Transnatio Hldgs I | 1.0 | $1.7M | 22k | 80.51 | |
| Insmed (INSM) | 0.8 | $1.5M | 85k | 17.51 | |
| Inotek Pharmaceuticals | 0.8 | $1.5M | 727k | 2.00 | |
| Coherus Biosciences (CHRS) | 0.8 | $1.3M | 64k | 21.14 | |
| Sunesis Pharmaceuticals Inc Ne | 0.7 | $1.3M | 312k | 4.10 | |
| Aeglea Biotherapeutics | 0.7 | $1.3M | 170k | 7.45 | |
| Vocera Communications | 0.7 | $1.2M | 50k | 24.82 | |
| Cerner Corporation | 0.7 | $1.2M | 20k | 58.85 | |
| Mazor Robotics Ltd. equities | 0.5 | $937k | 32k | 29.78 | |
| Flamel Technologies Sa (AVDL) | 0.5 | $885k | 91k | 9.68 | |
| Axsome Therapeutics (AXSM) | 0.5 | $819k | 210k | 3.90 | |
| Alnylam Pharmaceuticals (ALNY) | 0.4 | $692k | 14k | 51.26 | |
| Newlink Genetics Corporation | 0.3 | $613k | 25k | 24.11 | |
| Pfenex | 0.3 | $499k | 86k | 5.81 | |
| Oasmia Pharmaceutical Ab | 0.2 | $377k | 198k | 1.91 | |
| Forward Pharma A/s | 0.2 | $306k | 14k | 21.51 | |
| Biopharmx | 0.1 | $157k | 314k | 0.50 | |
| Anthera Pharmaceutcls | 0.1 | $144k | 334k | 0.43 |
